Non-invasive Testing for Helicobacter pylori in Patients Hospitalized with Peptic Ulcer Hemorrhage: A Cost-Effectiveness Analysis
- 234 Downloads
Guidelines recommend routine invasive screening for Helicobacter pylori in patients with peptic ulcer hemorrhage (PUH). However, compliance with screening remains suboptimal. The aim of this study was to determine if a simplified approach based on noninvasive screening is cost effective in PUH.
In the base case, post-endoscopy urea breath test (UBT) dominated the invasive testing with 34 fewer hemorrhages and cost savings of $406,600 in a cohort of 10,000 patients. When compliance with invasive testing decreases to 60%, post-endoscopy UBT leads to 109 fewer hemorrhages and cost savings of $1,089,600. The invasive strategy becomes the preferred choice if the sensitivity of UBT reduces to <75%, such as in patients taking proton-pump inhibitors (PPI) before hospitalization.
Post-endoscopy UBT is cost effective in PPI-naïve patients presenting with PUH. This strategy, once prospectively validated, can prove to be a preferred approach in institutions where compliance with invasive testing is suboptimal.
KeywordsHelicobacter pylori Peptic ulcer hemorrhage Cost-benefit analysis Breath tests/methods Carbon isotopes/diagnostic use
- H. pylori
Rapid urease test
Peptic ulcer hemorrhage
Urea breath test
Upper gastrointestinal bleed
Diagnoses Related Group
Current procedural terminology
Incremental cost-effectiveness ratio
Non-steroidal anti-inflammatory drugs
- 6.Gisbert JP, Khorrami S, Carballo F, et al. H. pylori eradication therapy vs. antisecretory non-eradication therapy (with or without long-term maintenance antisecretory therapy) for the prevention of recurrent bleeding from peptic ulcer. Cochrane Database Syst Rev. 2004;2:CD004062.PubMedGoogle Scholar
- 34.Stevens M, Livsey S, Swann R, et al. Evaluation of Sixteen EIAs for the Detection of Antibodies to Helicobacter pylori. London: Department of Health; 1997:1–46.Google Scholar
- 40.Santander C, Gravalos RG, Gomez-Cedenilla A, et al. Antimicrobial therapy for Helicobacter pylori infection versus long-term maintenance antisecretion treatment in the prevention of recurrent hemorrhage from peptic ulcer: Prospective nonrandomized trial on 125 patients. Am J Gastroenterol. 1996;91:1549–1552.PubMedGoogle Scholar
- 48.de Leest HTJI, Steen KSS, Lems WF, et al. Eradication of Helicobacter pylori does not reduce the incidence of gastroduodenal ulcers in patients on long-term NSAID treatment: Double-blind, randomized, placebo-controlled trial. Helicobacter. 2007;12(5):477–485. doi: 10.1111/j.1523-5378.2007.00543.x.CrossRefPubMedGoogle Scholar